Dechairo Bryan 4

What Happened
Dechairo Bryan, Chief Operating Officer of GeneDx Holdings Corp. (WGS), sold a total of 5,961 shares in open-market transactions on February 4, 2026, generating aggregate proceeds of approximately $510,875. The sales were reported in eight blocks with weighted average prices ranging from $83.04 to $91.92 per share (individual sale totals: 779 shares @ $83.04 = $64,684; 1,425 @ $83.83 = $119,456; 1,034 @ $84.93 = $87,816; 623 @ $86.35 = $53,796; 1,572 @ $87.66 = $137,804; 328 @ $88.66 = $29,082; 100 @ $90.45 = $9,045; 100 @ $91.92 = $9,192). These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. This is a sale (not a purchase) and is typically considered routine when done under a prearranged 10b5-1 plan.

Key Details

• Transaction date: February 4, 2026; Form 4 filed February 6, 2026 (timely filing).
• Total shares sold: 5,961; Total proceeds: ~$510,875.
• Reported prices are weighted averages; the sales occurred across price ranges of roughly $82.33–$91.92 per share (see footnotes for per-block ranges).
• Trades were executed under a Rule 10b5-1 plan adopted 9/15/2025 (footnote F1).
• Shares owned after the transactions: the reporting person beneficially owns RSUs representing contingent rights to receive up to 28,123 shares of Class A common stock (footnote F9).
• Transaction code: S = Sale.

Context
A 10b5-1 trading plan allows insiders to sell shares under a pre-set plan and is designed to reduce concerns that sales were based on non-public information; such sales are often routine and not necessarily a signal about company prospects. For retail investors, purchases by insiders may carry more weight as a bullish signal than routine, preplanned sales.